22nd Century Group Inc
NASDAQ:XXII
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
22nd Century Group Inc
NASDAQ:XXII
|
US |
|
Taiwan-Asia Semiconductor Corp
TWSE:2340
|
TW |
|
Immersion Corp
NASDAQ:IMMR
|
US |
22nd Century Group Inc
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. The company is headquartered in Williamsville, New York and currently employs 76 full-time employees. The company went IPO on 2006-10-17. The firm is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. In tobacco, hemp/cannabis, and hop plants, it uses various plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. The company has developed very low nicotine content (VLNC) tobacco and cigarettes, which contain 95% less nicotine than conventional tobacco and cigarettes. Its reduced nicotine cigarettes include VLN King and VLN Menthol King. In hemp, the Company is developing hemp varieties with increased levels of certain cannabinoids and other desirable agronomic traits.
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. The company is headquartered in Williamsville, New York and currently employs 76 full-time employees. The company went IPO on 2006-10-17. The firm is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. In tobacco, hemp/cannabis, and hop plants, it uses various plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. The company has developed very low nicotine content (VLNC) tobacco and cigarettes, which contain 95% less nicotine than conventional tobacco and cigarettes. Its reduced nicotine cigarettes include VLN King and VLN Menthol King. In hemp, the Company is developing hemp varieties with increased levels of certain cannabinoids and other desirable agronomic traits.
Transition year: Management said 2025 was a reset year, with the company exiting unprofitable businesses, cutting manufacturing overhead, and paying off remaining long-term debt to prepare for growth.
VLN rollout: 22nd Century said its VLN combustible cigarettes are now in 1,636 retail outlets across 23 states, with early signs of month-over-month growth as reorders begin to build.
2026 focus: The company expects 2026 to be a growth year, driven by more distribution, added marketing support, new products, and more headcount.
Balance sheet: The company ended 2025 with 0 long-term debt and later added about $5.6 million in cash from a financing round, bringing cash to more than $10 million.
Revenue shift: Revenue fell in 2025 as the company moved away from lower-margin contract manufacturing toward higher-margin branded VLN products, with management saying revenue should stay roughly flat in early 2026 before improving later in the year.
